Enterovirus 2A Cleavage of the YTHDF MA Readers Implicates YTHDF3 As a Mediator of Type I Interferon-Driven JAK/STAT Signaling
Overview
Authors
Affiliations
Enteroviruses (EV) deploy two proteases that mediate viral polyprotein cleavage and host cell manipulation. Here, we report that EV 2A proteases cleave all three members of the YTHDF protein family, cytosolic -methyladenosine (mA) "readers" that regulate target mRNA fate. YTHDF protein cleavage occurs very early during infection, before viral translation is detected or cytopathogenic effects are observed. Preemptive YTHDF protein depletion enhanced viral translation and replication but only in cells with restrained viral translation, signs of inefficient 2A protease activity, and protective innate host immune responses. This effect corresponded with repression of interferon (IFN)-stimulated gene (ISG) induction, while type I/III IFN production was not significantly altered. Moreover, YTHDF3 depletion impaired JAK/STAT signaling in cells treated with type I, but not type II, IFN. YTHDF3 depletion's stimulatory effect on viral dynamics was dampened by JAK/STAT blockade and enhanced by type I IFN pretreatment of cells. We propose that EV 2A proteases cleave YTHDF proteins to antagonize ISG induction in infected cells. It is believed that ∼7,000 messenger RNAs (mRNAs) are subject to -methyladenosine modification. The biological significance of this remains mysterious. The YTHDF mA readers are three related proteins with high affinity for mA-modified mRNA, yet their biological functions remain obscure. We discovered that polio/enteroviruses elicit very early proteolysis of YTHDF1 to 3 in infected cells. Our research demonstrates that YTHDF3 acts as a positive regulator of antiviral JAK/STAT signaling in response to positive single-strand RNA virus infection, enabling type I interferon (IFN)-mediated gene regulatory programs to unfurl in infected cells. Our observation of viral degradation of the YTHDF proteins demonstrates that they are key response modifiers in the innate antiviral immune response.
Update on enteroviral protease 2A: Structure, function, and host factor interaction.
Liu Y, Li J, Zhang Y Biosaf Health. 2025; 5(6):331-338.
PMID: 40078741 PMC: 11894969. DOI: 10.1016/j.bsheal.2023.09.001.
Zhao G, Zhang H, Chen Y, Shi K, Aghakeshmiri S, Yip F Microorganisms. 2024; 12(11).
PMID: 39597541 PMC: 11596310. DOI: 10.3390/microorganisms12112152.
Yun T, Hua J, Chen L, Ye W, Ni Z, Zhu Y Commun Biol. 2024; 7(1):1549.
PMID: 39572728 PMC: 11582818. DOI: 10.1038/s42003-024-07259-2.
Li F, Zeng C, Liu J, Wang L, Yuan X, Yuan L Clin Transl Med. 2024; 14(8):e1784.
PMID: 39135292 PMC: 11319238. DOI: 10.1002/ctm2.1784.
Recent insights into N-methyladenosine during viral infection.
Horner S, Reaves J Curr Opin Genet Dev. 2024; 87:102213.
PMID: 38901100 PMC: 11317213. DOI: 10.1016/j.gde.2024.102213.